LNC
32
3
BIIB
42
2
CA
32
3
SBUX
39
3
DNB
58
2
MAC
58
4
GM
63
2
FOXA
66
-3
KHC
13
-2
ADBE
55
4
PLD
45
5
CLX
65
2
MPC
33
2
IVZ
50
2
KSS
42
3
MS
72
2
HCP
54
-2
NEE
42
-2
EW
57
2
PHM
50
2
LNC
32
3
BIIB
42
2
CA
32
3
SBUX
39
3
DNB
58
2
MAC
58
4
GM
63
2
FOXA
66
-3
KHC
13
-2
ADBE
55
4
PLD
45
5
CLX
65
2
MPC
33
2
IVZ
50
2
KSS
42
3
MS
72
2
HCP
54
-2
NEE
42
-2
EW
57
2
PHM
50
2
Financhill
Back

Blueprint Medicines Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
27

BPMC
Blueprint Medicines

Last Price:
$91.65
Seasonality Move:
2.18%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Blueprint Medicines Stock Forecast

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 30.8% based on the past 9 years of stock performance.
  • Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Blueprint Medicines Stock Undervalued?
    The current Blueprint Medicines [BPMC] share price is $91.62. The Score for BPMC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Blueprint Medicines Stock Go Up Next Year?

  • Over the next 52 weeks, Blueprint Medicines has on average historically risen by 30.8% based on the past 9 years of stock performance.

Blueprint Medicines Stock Rating

Sell
27
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines overpriced?

  • Blueprint Medicines has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Blueprint Medicines Stock Price History

Is BPMC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com

52-Week Data

52-Week High:
121.90
52-Week Low:
72.24

Prediction Charts

Market Cap:
5.8B
Price in USD:
91.62
Volume:
267.9K
Beta:
0.88

Technical Analysis

SMA50:
92.53
SMA100:
91.67
SMA200:
96.72
52-Wk Change:
0.89%

Stock Predictions

  • Is Blueprint Medicines stock public?
    Yes, Blueprint Medicines is a publicly traded company.
  • What is the Blueprint Medicines stock quote today?
    The Blueprint Medicines stock price is 91.62 USD today.
  • How to buy Blueprint Medicines stock online?
    You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-6 95.60 95.97 97.04 94.33
Dec-9 96.29 94.57 97.00 94.44
Dec-10 95.23 95.39 97.44 94.47
Dec-11 95.32 94.47 97.00 93.41
Dec-12 94.13 92.58 94.91 92.17
Dec-13 92.72 93.19 93.77 92.00
Dec-16 93.17 95.39 96.09 91.88
Dec-17 94.59 96.48 96.98 94.55
Dec-18 97.05 91.78 98.41 91.16
Dec-19 91.84 88.93 92.29 86.02
Dec-20 88.12 90.19 90.99 87.99
Dec-23 89.69 90.33 90.99 88.70
Dec-24 90.77 90.46 90.77 89.22
Dec-26 90.22 91.62 91.99 89.47

Blueprint Medicines Earnings

Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.

Blueprint Medicines Forecast Revenue Growth

Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.